Systemic erythematous lupus , add mnemnics to remember easily
SLE systemic lupus erythematosus mnemonics criteria features remember medical
systemic lupus erythematosus malar rash butterfly rash clinical features

This clinical dermatology photograph displays the classic malar or butterfly rash of systemic lupus erythematosus (SLE) on the central face. Modality is clinical photography using standard white-light illumination; frontal/anterior view; color-balanced, high-resolution capture to depict superficial erythema and patchy hyperemia across the malar eminences and nasal bridge. The rash forms a bilateral, 'butterfly' distribution that typically reaches the cheeks and bridge of the nose while sparing the nasolabial folds. The observed features include confluent to patchy, erythematous macules and plaques with uniform erythema, mild perivascular edema, and subtle textural change without overt crusting or scaling in this image. The clinical morphology is characteristic for acute cutaneous lupus erythematosus; photosensitivity may exacerbate lesions. This cutaneous finding is one of the diagnostic criteria for SLE when aligned with serologic abnormalities (ANA, anti-dsDNA) and systemic features; its presence increases diagnostic probability in a compatible patient. Differential considerations include rosacea, seborrheic dermatitis, contact dermatitis, and dermatomyositis rash; however, the malar distribution and nasal bridge involvement help distinguish lupus. Clinically, this image supports SLE workup and educational reference for recognizing lupus-associated facial rash in medical students, residents, and researchers; useful for pattern-recognition training and multimodal data repository indexing. This image emphasizes clinical-context interpretation and education.

This clinical photograph displays a pediatric patient with dermatological manifestations consistent with Systemic Lupus Erythematosus (SLE). The image consists of two panels: a frontal view and a lateral close-up of the face. A distinctive malar rash, often referred to as a 'butterfly rash,' is visible across the nasal bridge and bilateral cheeks, notably sparing the nasolabial folds. The affected skin exhibits erythematous discoloration and an irregular texture. Higher magnification reveals atrophic scarring within the malar region, characterized by thin, slightly depressed skin with altered pigmentation. The forehead and peri-orbital regions appear relatively unaffected. These visual features are classic diagnostic markers for lupus-related skin involvement, illustrating the chronic inflammatory and sequela phases of the disease. The content is relevant for medical students and clinicians studying rheumatology, dermatology, and autoimmune connective tissue disorders.

This clinical photograph shows the facial features of a male patient presenting with cutaneous manifestations of Systemic Lupus Erythematosus (SLE). A characteristic malar rash is visible, appearing as erythematous, slightly edematous plaques distributed over the bridge of the nose and extending symmetrically across the cheeks in a 'butterfly' pattern, notably sparing the nasolabial folds. Additional findings include discoid lupus erythematosus (DLE) lesions on the lips, characterized by prominent scaling, crusting, and focal areas of depigmentation and hyperpigmentation along the vermilion border. Scattered erythematous macules are also present on the peri-orbital and malar regions. These visual signs are primary diagnostic indicators for autoimmune connective tissue diseases. The educational focus is on identifying the classic distribution of acute and chronic cutaneous lupus manifestations.

Two-panel clinical photograph (1A and 1B) illustrating cutaneous manifestations of Systemic Lupus Erythematosus (SLE). Image 1A shows a frontal view of a patient's face with a prominent erythematous malar rash extending across the bridge of the nose and cheeks. The rash demonstrates noticeable surface scaling and a characteristic sparing of the nasolabial folds, which is a classic diagnostic feature of the 'butterfly rash' in SLE. Image 1B displays the patient's posterior trunk (back), showing multiple scattered discoid-shaped lesions. These cutaneous lesions are erythematous with varying degrees of heaped-up, adherent scales on their surfaces, consistent with discoid lupus erythematosus (DLE) features. The visual presentation highlights key dermatologic findings used in the diagnosis and classification of autoimmune connective tissue diseases, focusing on morphology, scaling, and anatomical distribution.
lupus nephritis immunofluorescence wire loop lesion pathology

A composite medical image featuring four panels (A-D) illustrating clinical, radiological, and pathological findings of a complex case involving Lupus Nephritis and severe Herpes Zoster. Panel A is a light microscopy image (H&E stain) of a renal biopsy showing glomerular endothelial and mesangial hypercellularity with characteristic 'wire-loop' lesions, consistent with Class IV-G Lupus Nephritis. Panel B presents axial chest CT scans (lung and mediastinal windows) displaying bilateral, scattered patchy and nodular opacities with ill-defined borders, suggestive of diffuse alveolar hemorrhage. Panels C and D are clinical photographs of the neck and chest region showing the progression of skin lesions. Panel C depicts the acute phase of Herpes Zoster, characterized by confluent, grouped vesicles on an intense erythematous base extending across multiple dermatomes. Panel D shows the same region post-antiviral treatment, demonstrating resolving lesions with dried-up exudate and crusting on a fading erythematous base. This figure serves as an educational resource for multi-organ manifestations in immunocompromised patients, specifically highlighting systemic lupus erythematosus complications and disseminated viral infection.

This composite diagnostic image displays eight panels of renal immunofluorescence microscopy at 200x magnification, illustrating a 'full house' staining pattern diagnostic of Lupus Nephritis (LN). The panels show granular deposits of IgA, IgG, IgM, C3, C1q, Kappa, and Lambda light chains within the glomerulus. The staining for these immunoglobulins and complement components is diffuse and granular, involving the mesangium and capillary loops. The final panel demonstrates fibrinogen immunostaining, which exhibits high-intensity (3+) positivity. Unlike the more uniform granular appearance of the immunoglobulins, the fibrinogen staining is specifically localized to glomerular capillary structures, indicating fibrin deposition consistent with intraglomerular thrombi and thrombotic microangiopathy (TMA). This visual evidence is critical for the classification of Class IV Lupus Nephritis and for assessing the activity index of the disease through the presence of necrosis and thrombosis.
| Letter | Criterion |
|---|---|
| I | Immunologic disorders (anti-dsDNA, anti-Sm, antiphospholipid Ab) |
| M | Malar rash (butterfly rash over cheeks, spares nasolabial folds) |
| D | Discoid rash (erythematous raised patches with keratotic scaling) |
| A | ANA positive (antinuclear antibody) |
| M | Mucositis / oral/nasal ulcers (usually painless) |
| N | Neurologic disorders (seizures, psychosis, without other cause) |
| S | Serositis (pleuritis or pericarditis) |
| H | Hematologic disorders (hemolytic anemia, leukopenia <4000, thrombocytopenia <100k) |
| A | Arthritis (non-erosive, ≥2 peripheral joints, with tenderness/swelling) |
| R | Renal disorders (proteinuria >0.5 g/day or cellular casts) |
| P | Photosensitivity (skin rash from UV exposure) |
Remember: 4 out of 11 criteria required (serially or simultaneously).
| Letter | Antibody | Significance |
|---|---|---|
| D | Anti-dsDNA | Highly specific for SLE; correlates with disease activity and nephritis |
| A | ANA | Most sensitive (~95-99%); screening test |
| M | Anti-Sm (Smith) | Highly specific for SLE (virtually diagnostic); does NOT fluctuate with activity |
| S | Anti-SS-A/Ro, Anti-SS-B/La | Associated with neonatal lupus, congenital heart block |
| Letter | Finding |
|---|---|
| H | Hair loss (non-scarring alopecia) |
| E | Erythema (malar butterfly rash) |
| L | Libman-Sacks endocarditis (verrucous, non-bacterial) |
| P | Photosensitivity |
| O | Oral/nasal ulcers |
| D | Discoid rash |


| Letter | System |
|---|---|
| C | Cardiovascular - Libman-Sacks endocarditis, pericarditis, accelerated atherosclerosis |
| A | Arthritis/joints - non-erosive, non-deforming (Jaccoud's arthropathy) |
| S | Skin - malar rash, discoid rash, photosensitivity, alopecia |
| H | Hematology - hemolytic anemia, leukopenia, thrombocytopenia |
| K | Kidney (renal) - lupus nephritis (most serious; wire-loop lesions in Class IV) |
| A | Auto-antibodies / immunologic |
| N | Neuro-psychiatric - seizures, psychosis, stroke |
| Class | Type | Memory trick |
|---|---|---|
| I | Minimal mesangial | Minimal = "Mild, mesangial only" |
| II | Mesangial proliferative | Mesangial proliferative |
| III | Focal (< 50% glomeruli) | Focal = "Few affected" |
| IV | Diffuse (> 50% glomeruli) | Diffuse = "Dangerous, worst prognosis"; wire-loop lesions |
| V | Membranous | Membranous = nephrotic syndrome |
| VI | Sclerosing | Sclerosis = end-stage |
Wire-loop lesion = subendothelial immune complex deposits in Class IV - seen on H&E as thickened, rigid capillary loops.
| Letter | Drug |
|---|---|
| H | Hydralazine |
| I | Isoniazid (INH) |
| P | Procainamide (most common offender) |
| P | Penicillamine |
| S | Sulfonamides |
Drug-induced lupus: Anti-histone antibodies are the hallmark. Rare renal/CNS involvement. Resolves on stopping the drug.
| Feature | SLE | RA |
|---|---|---|
| Synovitis | Mild | Severe |
| Affects | MCP, PIP joints | MCP, PIP, MTP |
| Non-erosive | Yes (SLE) | No (erosive in RA) |
| Erosions | Absent | Present |
| Feature | Memory Hook |
|---|---|
| Most specific antibody | Anti-dsDNA & Anti-Sm ("Sm = Specific Marker") |
| Most sensitive antibody | ANA ("Always Noticed in SLE - Sensitive") |
| Neonatal lupus | Anti-Ro/SS-A ("Ro = ROcks the baby") |
| Antiphospholipid syndrome | Recurrent thrombosis + fetal loss ("CLOT = Coagulation, Lupus anticoagulant, Obsteric loss, Thrombocytopenia") |
| Complement levels | Low C3/C4 in active disease ("Consumed = Active") |
| Libman-Sacks | Verrucous endocarditis on BOTH sides of mitral valve ("Both sides = Lupus, not Rheumatic fever") |
| Letter | Drug |
|---|---|
| H | Hydroxychloroquine (for ALL SLE patients; prevents flares) |
| A | Azathioprine (maintenance immunosuppression) |
| M | Methotrexate (for skin/joints) |
| C | Corticosteroids (for acute flares and organ-threatening disease) |
| H | High-dose pulse methylprednisolone (severe nephritis/CNS) |
| I | IV Cyclophosphamide (induction therapy for Class III/IV nephritis) |
SLE = "9:1 Female, 4 of 11 criteria"
Criteria = I'M DAMN SHARP
Antibodies = ANA (sensitive) + anti-dsDNA/Sm (specific)
Worst organ = KIDNEY (Class IV diffuse proliferative, wire-loop lesions)
Drug-induced = HIPPS (Hydralazine, INH, Procainamide, Penicillamine, Sulfonamides)
Never miss = Hydroxychloroquine for every SLE patient
Pathogenesis flowchart
A detailed medical pathogenesis flowchart for Systemic Lupus Erythematosus (SLE). Clean, professional medical education style with a white background, clear boxes and arrows. The flowchart should show these sequential and parallel steps: TOP ROW - Triggers (3 boxes side by side): - "Genetic Factors: HLA-DQ alleles, C1q/C2/C4 deficiency, TLR/IFN gene polymorphisms" - "Environmental Triggers: UV light, Drugs (hydralazine, procainamide), Viral infections, Estrogens" - "Apoptotic Cell Failure: Defective clearance of apoptotic debris → nuclear antigens exposed" All three converge with arrows to a central box: "FAILURE OF SELF-TOLERANCE (Loss of central & peripheral B and T cell tolerance)" Then arrow down to: "Activation of Self-Reactive B & T Cells" (with sub-note: TLR engagement by DNA/RNA in immune complexes; Type I IFN surge from plasmacytoid dendritic cells) Arrow down to TWO parallel boxes: LEFT: "Autoantibody Production: ANA (95-99%), Anti-dsDNA (40-60%), Anti-Sm (20-30%), Anti-Ro/La, Antiphospholipid Ab" RIGHT: "Type I IFN Signature (Interferon Storm): Activates DCs, B cells, Th cells → amplification loop" Both arrows converge down to: "IMMUNE COMPLEX FORMATION (Anti-dsDNA + dsDNA complexes)" Arrow down to: "Immune Complex Deposition in Tissues" Arrow down to THREE parallel outcome boxes: - "Kidneys: Glomerulonephritis (Wire-loop lesions, Class IV diffuse proliferative LN)" - "Skin: Malar rash, Vasculitis, Complement activation → inflammation" - "Joints / CNS / Heart / Lungs: Synovitis, Seizures, Libman-Sacks endocarditis, Serositis" Final arrow down to: "TISSUE DAMAGE & ORGAN DYSFUNCTION" (bold, red text box) Use blue and teal for boxes, red for the final outcome box, dark gray arrows. Add a small legend noting: Type I IFN = key amplifier; NETs = neutrophil extracellular traps also activate pDCs

| Antibody | Prevalence in SLE | Key Significance |
|---|---|---|
| ANA | 95-99% | Most sensitive (screening) |
| Anti-dsDNA | 40-60% | Specific; tracks disease activity + nephritis |
| Anti-Sm | 20-30% | Highly specific; diagnostic |
| Anti-Ro/SS-A | ~30% | Neonatal lupus, congenital heart block |
| Antiphospholipid | ~10% | Thrombosis, recurrent miscarriage |
| Organ | Mechanism | Lesion |
|---|---|---|
| Kidney | IC deposition in glomeruli | Wire-loop lesions (Class IV diffuse proliferative LN) |
| Skin | Complement activation, vasculitis | Malar rash, discoid rash |
| Heart | IC deposition on valve leaflets | Libman-Sacks endocarditis (both sides of mitral valve) |
| Joints | Synovial inflammation | Non-erosive arthritis |
| CNS | Vasculitis, antineuronal antibodies, antiphospholipid Abs | Seizures, psychosis, stroke |
| Blood vessels | IC-mediated vasculitis | Raynaud's, purpura |
| Blood cells | Anti-RBC (hemolysis), anti-platelet, anti-WBC Abs | Hemolytic anemia, thrombocytopenia, leukopenia |
Apoptotic debris → autoantibodies → immune complexes
↑ ↓
More tissue damage ← complement activation ← IC deposition